Marketing Authorization Renewal in Vietnam in 2025

Marketing Authorization Renewal in Vietnam in 2023 Step-by-Step Guide to Marketing Authorization Renewal in Vietnam in 2023 In the realm of pharmaceutical and biopharmaceutical products, ensuring compliance with local regulations is paramount for successful market access. For companies operating in Vietnam, understanding the drug registration process, particularly the marketing authorization renewal, is essential to maintain their presence in the market. This article serves as a detailed step-by-step guide for regulatory affairs professionals, Quality Assurance (QA) personnel, and Clinical teams involved in this process. Step 1: Understanding the Regulatory Framework in Vietnam Before initiating the marketing authorization renewal process, it is…

Continue Reading... Marketing Authorization Renewal in Vietnam in 2025

DAV Requirements for Biologics and Biosimilars in 2025

DAV Requirements for Biologics and Biosimilars in 2023 DAV Requirements for Biologics and Biosimilars in 2023 In the rapidly evolving field of pharmaceuticals, understanding the specific requirements and regulatory pathways for drug registration is crucial, particularly in emerging markets like Vietnam. The Department of Drug Administration of Vietnam (DAV) lays out clear regulations for the approval of biologics and biosimilars. This article serves as a comprehensive step-by-step tutorial intended for regulatory affairs professionals seeking to navigate the complexities of the Vietnam DAV drug registration process for these products in 2023. Major segments include drug registration, market authorization, and post-approval commitments,…

Continue Reading... DAV Requirements for Biologics and Biosimilars in 2025

Pharmacovigilance and Safety Reporting to DAV in 2025

Pharmacovigilance and Safety Reporting to DAV in Pharmacovigilance and Safety Reporting to DAV in As the landscape of pharmaceutical regulation evolves, maintaining compliance with pharmacovigilance and safety reporting requirements is crucial, particularly for entities operating in Vietnam. The Drug Administration of Vietnam (DAV) serves as the authoritative body overseeing regulatory compliance, including drug registration and pharmacovigilance processes. This article provides a comprehensive step-by-step tutorial on the pharmacovigilance and safety reporting requirements to the DAV in , catering specifically to professionals in regulatory affairs, quality assurance, clinical trials and market access. Step 1: Understanding the Regulatory Framework Before initiating the pharmacovigilance…

Continue Reading... Pharmacovigilance and Safety Reporting to DAV in 2025

Handling DAV Queries and Regulatory Deficiencies

Handling DAV Queries and Regulatory Deficiencies Handling DAV Queries and Regulatory Deficiencies Step 1: Understanding the Role of the Drug Administration of Vietnam (DAV) The Drug Administration of Vietnam (DAV) plays a critical role in the drug registration process and the overall management of pharmaceutical products in Vietnam. Before engaging with the DAV, it is essential for regulatory professionals to understand its functions, responsibilities, and the legal framework that governs its operations. The DAV operates under the Ministry of Health (MoH) and is responsible for the registration of pharmaceutical products, monitoring drug safety, and ensuring compliance with good manufacturing practices…

Continue Reading... Handling DAV Queries and Regulatory Deficiencies

Stability Data Expectations for Vietnam Market Approval in 2025

Stability Data Expectations for Vietnam Market Approval in 2023 Stability Data Expectations for Vietnam Market Approval in 2023 The approval of pharmaceutical products in Vietnam requires meticulous compliance with the regulations set forth by the Drug Administration of Vietnam (DAV). One pivotal element in this process is the stability data demonstrating the product’s shelf life and efficacy throughout its intended use period. This article outlines a detailed step-by-step guide to the stability data expectations for market authorization in Vietnam. Step 1: Understanding Regulatory Framework and Requirements Before embarking on the stability data preparation for drug registration in Vietnam, a comprehensive…

Continue Reading... Stability Data Expectations for Vietnam Market Approval in 2025

Fast Track and Special Approval Pathways in Vietnam in 2025

Fast Track and Special Approval Pathways in Vietnam in 2023 Fast Track and Special Approval Pathways in Vietnam in 2023 The landscape of pharmaceutical regulation in Vietnam is continuously evolving, and understanding fast track and special approval pathways is essential for successful drug registration. This comprehensive guide offers regulatory affairs professionals a step-by-step approach to navigate the approval process effectively and efficiently. Step 1: Understanding Regulatory Framework in Vietnam Before engaging with the Vietnam Drug Administration (DAV), it is imperative to comprehend the regulatory framework governing drug registration. The legal basis for drug registration primarily stems from the Law on…

Continue Reading... Fast Track and Special Approval Pathways in Vietnam in 2025

Managing Local MAH and Distributors in Vietnam

Managing Local MAH and Distributors in Vietnam Managing Local MAH and Distributors in Vietnam Managing local marketing authorization holders (MAH) and distributors in Vietnam is a crucial component of regulatory affairs for pharmaceutical products. This step-by-step tutorial guide provides comprehensive practices and expectations for professionals involved in drug registration, ensuring compliance with the Drug Administration of Vietnam (DAV) regulations. By following these outlined steps, stakeholders will gain clarity in navigating the regulatory landscape while optimizing market access in Vietnam. Step 1: Understanding the Regulatory Framework The regulatory framework governing drug registration in Vietnam is primarily overseen by the Drug Administration…

Continue Reading... Managing Local MAH and Distributors in Vietnam

Common DAV Submission Errors and Regulatory Pitfalls in 2025

Common DAV Submission Errors and Regulatory Pitfalls in 2023 Common DAV Submission Errors and Regulatory Pitfalls in 2023 The process of drug registration in Vietnam, overseen by the Drug Administration of Vietnam (DAV), can be intricate and challenging, particularly for those navigating it for the first time. This article aims to provide a comprehensive, step-by-step guide to help regulatory affairs professionals identify and mitigate common errors encountered during the drug registration process. By understanding the submission pathways and requirements, professionals can ensure compliance and smooth market authorization. This guide is particularly useful for those engaged in the role of a…

Continue Reading... Common DAV Submission Errors and Regulatory Pitfalls in 2025

ASEAN Harmonization Impact on Vietnam Drug Approvals in 2025

ASEAN Harmonization Impact on Vietnam Drug Approvals in 2023 ASEAN Harmonization Impact on Vietnam Drug Approvals in 2023 The harmonization of regulatory processes across ASEAN (Association of Southeast Asian Nations) members, particularly Vietnam, offers significant implications for drug approvals in 2023. Understanding these changes is crucial for stakeholders involved in the Vietnam DAV drug registration process. This article will provide a step-by-step guide, detailing practical actions and documentation expectations, tailored for regulatory affairs professionals, quality assurance experts, and clinical researchers. Step 1: Understanding ASEAN Harmonization Guidelines ASEAN member countries have made strides toward regulatory harmonization to improve cross-border trade and…

Continue Reading... ASEAN Harmonization Impact on Vietnam Drug Approvals in 2025

Inspection Readiness for DAV GMP Audits in 2025

Inspection Readiness for DAV GMP Audits in 2023 Inspection Readiness for DAV GMP Audits in 2023 Step 1: Understanding the Regulatory Framework for DAV GMP Audits In order to achieve compliance with the Vietnam Drug Administration (DAV) regarding Good Manufacturing Practices (GMP), it is imperative to understand the existing regulatory framework. This includes adherence to guidelines provided by the Ministry of Health (MoH) in Vietnam and the World Health Organization (WHO) recommendations on GMP. Furthermore, the ability to navigate the regulatory landscape efficiently requires comprehensive knowledge of local regulations, as well as global standards. The GMP framework as defined by…

Continue Reading... Inspection Readiness for DAV GMP Audits in 2025